232 related articles for article (PubMed ID: 22119647)
1. Modulation of CNS pain circuitry by intravenous and sublingual doses of buprenorphine.
Upadhyay J; Anderson J; Baumgartner R; Coimbra A; Schwarz AJ; Pendse G; Wallin D; Nutile L; Bishop J; George E; Elman I; Sunkaraneni S; Maier G; Iyengar S; Evelhoch JL; Bleakman D; Hargreaves R; Becerra L; Borsook D
Neuroimage; 2012 Feb; 59(4):3762-73. PubMed ID: 22119647
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study.
Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J
Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544
[TBL] [Abstract][Full Text] [Related]
3. Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model.
Koppert W; Ihmsen H; Körber N; Wehrfritz A; Sittl R; Schmelz M; Schüttler J
Pain; 2005 Nov; 118(1-2):15-22. PubMed ID: 16154698
[TBL] [Abstract][Full Text] [Related]
4. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study.
Sorge J; Sittl R
Clin Ther; 2004 Nov; 26(11):1808-20. PubMed ID: 15639693
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of transdermal buprenorphine: a randomized, placebo-controlled trial in 289 patients with severe cancer pain.
Poulain P; Denier W; Douma J; Hoerauf K; Samija M; Sopata M; Wolfram G
J Pain Symptom Manage; 2008 Aug; 36(2):117-25. PubMed ID: 18411010
[TBL] [Abstract][Full Text] [Related]
6. Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgery.
Oifa S; Sydoruk T; White I; Ekstein MP; Marouani N; Chazan S; Skornick Y; Weinbroum AA
Clin Ther; 2009 Mar; 31(3):527-41. PubMed ID: 19393843
[TBL] [Abstract][Full Text] [Related]
7. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
8. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
Kögel B; Christoph T; Strassburger W; Friderichs E
Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
[TBL] [Abstract][Full Text] [Related]
9. Differential sensitivity of three experimental pain models in detecting the analgesic effects of transdermal fentanyl and buprenorphine.
Koltzenburg M; Pokorny R; Gasser UE; Richarz U
Pain; 2006 Dec; 126(1-3):165-74. PubMed ID: 16901645
[TBL] [Abstract][Full Text] [Related]
10. Parallel buprenorphine phMRI responses in conscious rodents and healthy human subjects.
Becerra L; Upadhyay J; Chang PC; Bishop J; Anderson J; Baumgartner R; Schwarz AJ; Coimbra A; Wallin D; Nutile L; George E; Maier G; Sunkaraneni S; Iyengar S; Evelhoch JL; Bleakman D; Hargreaves R; Borsook D
J Pharmacol Exp Ther; 2013 Apr; 345(1):41-51. PubMed ID: 23370795
[TBL] [Abstract][Full Text] [Related]
11. Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series.
Martin YN; Deljou A; Weingarten TN; Schroeder DR; Sprung J
BMC Anesthesiol; 2019 May; 19(1):68. PubMed ID: 31068127
[TBL] [Abstract][Full Text] [Related]
12. Buprenorphine/Naloxone dose and pain intensity among individuals initiating treatment for opioid use disorder.
Becker WC; Ganoczy D; Fiellin DA; Bohnert AS
J Subst Abuse Treat; 2015 Jan; 48(1):128-31. PubMed ID: 25312475
[TBL] [Abstract][Full Text] [Related]
13. Comparisons of analgesic potency and side effects of buprenorphine and buprenorphine with ultra-low-dose naloxone.
Ling W; Hillhouse M; Jenkins J; Miotto K; Torrington M; Chapleo C
J Addict Med; 2012 Jun; 6(2):118-23. PubMed ID: 22475985
[TBL] [Abstract][Full Text] [Related]
14. Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine.
Mercadante S; Villari P; Ferrera P; Porzio G; Aielli F; Verna L; Casuccio A
J Pain Symptom Manage; 2006 Aug; 32(2):175-9. PubMed ID: 16877185
[TBL] [Abstract][Full Text] [Related]
15. Anti-hyperalgesia properties of buprenorphine.
Russo MA
Pain; 2006 May; 122(1-2):216; author reply 216. PubMed ID: 16524662
[No Abstract] [Full Text] [Related]
16. A physiologically based pharmacokinetic modelling approach to predict buprenorphine pharmacokinetics following intravenous and sublingual administration.
Kalluri HV; Zhang H; Caritis SN; Venkataramanan R
Br J Clin Pharmacol; 2017 Nov; 83(11):2458-2473. PubMed ID: 28688108
[TBL] [Abstract][Full Text] [Related]
17. Enhanced buprenorphine analgesia with the addition of ultra-low-dose naloxone in healthy subjects.
La Vincente SF; White JM; Somogyi AA; Bochner F; Chapleo CB
Clin Pharmacol Ther; 2008 Jan; 83(1):144-52. PubMed ID: 17568402
[TBL] [Abstract][Full Text] [Related]
18. Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials.
Likar R; Kayser H; Sittl R
Clin Ther; 2006 Jun; 28(6):943-52. PubMed ID: 16860176
[TBL] [Abstract][Full Text] [Related]
19. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR
Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
[TBL] [Abstract][Full Text] [Related]
20. Interaction of fentanyl and buprenorphine in an experimental model of pain and central sensitization in human volunteers.
Tröster A; Ihmsen H; Singler B; Filitz J; Koppert W
Clin J Pain; 2012 Oct; 28(8):705-11. PubMed ID: 22469638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
